👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

Dollar dips on vaccine doubts, kiwi soars after RBNZ

Published 11/10/2020, 07:31 PM
Updated 11/11/2020, 12:10 AM
© Reuters. FILE PHOTO: U.S. dollars and other world currencies lie in a charity receptacle at Pearson international airport in Toronto
EUR/USD
-
EUR/GBP
-
PFE
-
DX
-
ILS/UAH
-
BNTX
-

By Stanley White

TOKYO (Reuters) - The dollar fell on Wednesday as optimism about a potential coronavirus vaccine was offset by worries about how the drug will be delivered and by a surge of new infections in the United States.

The New Zealand dollar recovered from an early dip to hit its strongest level in more than a year as traders scaled back bets that the central bank would move to negative interest rates.

Initial optimism about coronavirus vaccine testing pushed the dollar up against the safe-harbour yen and the Swiss franc, but this momentum is starting to fade because there are still several obstacles to clear before a vaccine can be distributed.

"The dollar recovery is on hold for now because, when you look at the details, there are still a lot of hurdles to clear before any vaccine is rolled out," said Junichi Ishikawa, senior foreign exchange strategist at IG Securities in Tokyo.

"However, the dollar is supported by rising Treasury yields, which should help the dollar make another push higher before year's end."

The dollar fell 0.15% to 105.07 yen , pulling back from a three-week high.

Against the euro (EUR=D3), the dollar eased slightly to $1.1829.

The British pound traded at $1.3273, close to a two-month high due to growing optimism that Britain and the European Union will agree a long-sought-after trade deal.

Sterling, however, surrendered some of its overnight gains against the euro (EURGBP=).

Sentiment for the dollar got a boost after Pfizer Inc (N:PFE) and BioNTech (DE:22UAy) said on Monday their experimental coronavirus vaccine was 90% effective.

However, the reaction across financial markets has become more tempered because there are several logistical hurdles to making the drug available, including that it has to be shipped at extremely cold temperatures.

Several U.S. states on Tuesday imposed restrictions to curb the spread of the coronavirus as hospitalizations soared, highlighting the difficulty in containing the virus as winter in the Northern Hemisphere approaches.

The dollar index (=USD) against a basket of six major currencies fell slightly to 92.633.

The onshore yuan capitalised on the dollar's weakness and rose to 6.5926.

Other Asian currencies, such as the Korean won and the Singapore dollar , also gained against the greenback.

The New Zealand dollar hit $0.6868, its strongest since March 2019.

The Reserve Bank of New Zealand (RBNZ) kept interest rates on hold at 0.25% and introduced a new monetary policy tool to encourage more loans by reducing borrowing costs for banks, which matched market expectations.

RBNZ Governor Adrian Orr also said domestic economic activity since August has been more resilient than previously assumed, which many traders took as a sign that the chance of negative interest rates has receded.

© Reuters. FILE PHOTO: U.S. dollars and other world currencies lie in a charity receptacle at Pearson international airport in Toronto

Across the Tasman Sea, the Australian dollar also rose against its U.S. counterpart.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.